Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective inhibition of STAT3 transcriptional activity by novel small molecules alleviates the development of lupus in mice.

Translational research : the journal of laboratory and clinical medicine·2026
Same author

Laboratory Assessment and Clinical Outlook for <i>Ex Vivo</i>-Produced Human Platelets and Megakaryocytes from Stem Cell Sources.

Annals of laboratory medicine·2026
Same author

Comparative Performance Evaluation of Multi-Type LiDAR Sensors and Their Applicability to Sidewalk HD Mapping.

Sensors (Basel, Switzerland)·2026
Same author

Ubiquitin-mediated stabilization of KDM5B drives chemoresistance via repression of dual-specificity phosphatase 4 in ovarian cancer.

Signal transduction and targeted therapy·2026
Same author

Actin dysregulation induces neuroendocrine plasticity and immune evasion: a vulnerability of small cell lung cancer.

Nature communications·2025
Same author

KDM4A promotes NEPC progression through regulation of MYC expression.

Cancer letters·2025

Related Experiment Video

Updated: Jun 20, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

9.6K

Transcriptomics-Based Repositioning of Natural Compound, Eudesmin, as a PRC2 Modulator.

Sang Ah Yi1, Ki Hong Nam1, Min Gyu Lee1

  • 1School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea.

Molecules (Basel, Switzerland)
|September 28, 2021
PubMed
Summary

Eudesmin treatment enriches Polycomb Repressive Complex 2 (PRC2) target genes, downregulating Wnt signaling and maintaining stem cell pluripotency. This study reveals eudesmin

Keywords:
eudesminpluripotencypolycomb repressive complex 2transcriptomewnt

More Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.4K
Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

413

Related Experiment Videos

Last Updated: Jun 20, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

9.6K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.4K
Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

413

Area of Science:

  • Epigenetics
  • Stem Cell Biology
  • Molecular Pharmacology

Background:

  • Extensive epigenetic remodeling is crucial for stem cell fate determination.
  • Eudesmin was previously found to regulate mesenchymal stem cell lineage commitment by inhibiting signaling molecules.
  • Genomewide epigenetic changes induced by eudesmin were not previously characterized.

Purpose of the Study:

  • To investigate the genomewide epigenetic modulations induced by eudesmin treatment in stem cells.
  • To identify the role of Polycomb Repressive Complex 2 (PRC2) in eudesmin-mediated epigenetic regulation.
  • To elucidate the impact of eudesmin on Wnt signaling and stem cell pluripotency.

Main Methods:

  • Transcriptome profiling to identify PRC2 target genes affected by eudesmin.
  • Gene Ontology (GO) analysis to determine the functional pathways of downregulated PRC2 target genes.
  • Chromatin Immunoprecipitation followed by quantitative PCR (ChIP-qPCR) and reverse transcription quantitative PCR (RT-qPCR) to analyze PRC2 occupancy and gene expression.
  • Analysis of Gene Expression Omnibus (GEO) profiles to compare gene expression patterns.

Main Results:

  • Eudesmin treatment led to the enrichment of PRC2 target genes.
  • Downregulated PRC2 target genes were associated with Wnt signaling and pluripotency pathways, with DKK1 identified as a key hub gene.
  • Eudesmin treatment increased PRC2 component (EZH2, SUZ12) occupancy and H3K27me3 levels at the DKK1 promoter, suppressing its transcription.
  • Gene expression changes induced by eudesmin showed an inverse pattern to those caused by Oct4 depletion, with upregulation of pluripotency markers (Oct4, Sox2, Nanog).

Conclusions:

  • Pharmacological modulation of PRC2 dynamics by eudesmin can control Wnt signaling.
  • Eudesmin treatment promotes the maintenance of stem cell pluripotency.
  • These findings highlight a novel mechanism by which eudesmin influences stem cell fate through epigenetic regulation of PRC2.